Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cythioate is an organothiophosphate compound used primarily as a veterinary insecticide and anthelmintic. It is indicated for the control of fleas and ticks in dogs, demodectic mange in dogs, and fleas in cats. Cythioate acts as a **cholinesterase inhibitor**, interfering with the normal function of acetylcholinesterase enzymes in parasites, leading to their paralysis and death. It is administered orally and has been marketed under the trade names Cyflee and Proban since at least the late 1960s. Its use is mainly restricted to veterinary medicine. Developed by American Cyanamid.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cythioate.